# BiPhasic Cartilage Repair Implant (BiCRI) IDE Clinical Trial - Taiwan

> **NCT01477008** · NA · COMPLETED · sponsor: **BioGend Therapeutics Co.Ltd** · enrollment: 92 (actual)

## Conditions studied

- Chondral or Osteochondral Lesion of Medial Femoral Condyle
- Chondral or Osteochondral Lesion of Lateral Femoral Condyle
- Chondral or Osteochondral Lesion of Trochlea

## Interventions

- **DEVICE:** BiPhasic Cartilage Repair Implant
- **PROCEDURE:** Marrow Stimulation

## Key facts

- **NCT ID:** NCT01477008
- **Lead sponsor:** BioGend Therapeutics Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2019-04
- **Final completion:** 2019-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2022-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01477008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01477008, "BiPhasic Cartilage Repair Implant (BiCRI) IDE Clinical Trial - Taiwan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01477008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*